Synthesis, structural characterization and biological study of new organotin(IV), silver(I) and antimony(III) complexes with thioamides.
暂无分享,去创建一个
M. Xanthopoulou | N. Hadjiliadis | S K Hadjikakou | I I Ozturk | M N Xanthopoulou | P C Zachariadis | S Zartilas | S Karkabounas | N Hadjiliadis | S. Karkabounas | S. Hadjikakou | P. C. Zachariadis | I. Ozturk | S. Zartilas
[1] S. Skoulika,et al. Synthesis, structural characterization, and biological studies of six- and five-coordinate organotin(IV) complexes with the thioamides 2-mercaptobenzothiazole, 5-chloro-2-mercaptobenzothiazole, and 2-mercaptobenzoxazole. , 2007, Inorganic chemistry.
[2] J. Vicente,et al. Complexes with S-Donor Ligands, 4. Mono- and Di-Homo- and -Hetero-Nuclear Gold(I), Silver(I), and Palladium(II) Complexes with 2-(Methylthio)pyridine, Pyridine-2(1H)-thione, and Benzoxazole-2(3H)-thione. Some Examples of the Use of Complexes as Ligands† , 1996 .
[3] J. Trosko,et al. Platinum Compounds: a New Class of Potent Antitumour Agents , 1969, Nature.
[4] K. Jurkschat,et al. Synthesis, structural characterization and in vitro cytotoxicity of organotin(IV) derivatives of heterocyclic thioamides, 2-mercaptobenzothiazole, 5-chloro-2-mercaptobenzothiazole, 3-methyl-2-mercaptobenzothiazole and 2-mercaptonicotinic acid. , 2003, Journal of inorganic biochemistry.
[5] E. Tiekink. Antimony and bismuth compounds in oncology. , 2002, Critical reviews in oncology/hematology.
[6] J. Roberts,et al. Cross-linking of Complementary Strands of DNA in Mammalian Cells by Antitumour Platinum Compounds , 1972, Nature.
[7] J. Jordanov,et al. Anti-tumour activity of heavy transition metal complexes against hepatoma cells. , 1975, Chemico-biological interactions.
[8] M. Guo,et al. Interactions of organometallic anticancer agents with nucleotides and DNA , 1999 .
[9] M. Pariza,et al. Newly recognized anticarcinogenic fatty acids: identification and quantification in natural and processed cheeses , 1989 .
[10] T. Bakas,et al. Interaction of Et2SnCl2 with 5'-IMP and 5'-GMP. , 1998, Journal of inorganic biochemistry.
[11] H S Rosenkranz,et al. Silver Sulfadiazine: Interaction with Isolated Deoxyribonucleic Acid , 1972, Antimicrobial Agents and Chemotherapy.
[12] A. Michaelides,et al. Synthesis, study and structural characterization of a new water soluble hexanuclear silver(I) cluster with the 2-mercapto-nicotinic acid with possible antiviral activity , 2003 .
[13] K. Jurkschat,et al. Communication: Synthesis of a Novel Triphenyltin(IV) Derivative of 2- Mercaptonicotinic Acid with Potent Cytotoxicity in vitro , 2003, Bioinorganic Chemistry and Applications.
[14] N. Hadjiliadis,et al. A New Silver(I) Aggregate Having an Octagonal Ag4S4 Core Where μ3‐S Bonding Interactions Lead to a Nanotube Assembly that Exhibits Quasiaromaticity , 2007 .
[15] M. Xanthopoulou,et al. Biological studies of new organotin(IV) complexes of thioamide ligands. , 2008, European journal of medicinal chemistry.
[16] H. Schmidbaur,et al. Assembly of the [CAu6]2⊕ Cluster with a Tailor‐made Diphosphane Spanning the Octahedral Edges , 1990 .
[17] Edward R. T. Tiekink,et al. Metallotherapeutic Drugs and Metal-Based Diagnostic Agents: The Use of Metals in Medicine , 2005 .
[18] H. Schmidbaur,et al. Aufbau des [CAu6]2⊕-Clusters mit einem maßgeschneiderten, die Oktaederkanten überspannenden Diphosphan† , 1990 .
[19] F. Huber,et al. Organotin compounds and cancer chemotherapy , 1989 .
[20] N. Hadjiliadis,et al. Synthesis and characterization of new water stable antimony(III) complex with pyrimidine-2-thione and in vitro biological study , 2005 .
[21] E. S. Raper. Complexes of heterocyclic thione donors , 1985 .
[22] W. Isaacs,et al. Cyclooxygenases in cancer: progress and perspective. , 2004, Cancer letters.
[23] Jan Balzarini,et al. Synthesis, Characterization and in Vitro Study of the Cytostatic and Antiviral Activity of New Polymeric Silver(I) Complexes with Ribbon Structures Derived from the Conjugated Heterocyclic Thioamide 2-Mercapto-3,4,5,6-tetra- hydropyrimidine , 2004 .
[24] P. Sadler,et al. Medicinal Inorganic Chemistry , 1999 .
[25] W. R. Porter,et al. The pharmacology and metabolism of the thiopurine drugs 6-mercaptopurine and azathioprine. , 1985, Drug metabolism reviews.
[26] M. Gielen. Review: Organotin compounds and their therapeutic potential: a report from the Organometallic Chemistry Department of the Free University of Brussels , 2002 .
[27] J. Balzarini,et al. Synthesis, structural characterization, and biological studies of new antimony(III) complexes with thiones. The influence of the solvent on the geometry of the complexes. , 2007, Inorganic chemistry.
[28] L. Pellerito,et al. Organotin(IV)n+ complexes formed with biologically active ligands: equilibrium and structural studies, and some biological aspects , 2002 .
[29] J. Martins,et al. Multinuclear 1D and 2D NMR investigations on the interaction between the pyrimidic nucleotides 5 '-CMP, 5 '-dCMP, and 5 '-UMP and diethyltin dichloride in aqueous medium , 2000 .
[30] Jan Balzarini,et al. Tetrameric 1:1 and monomeric 1:3 complexes of silver(I) halides with tri( p -tolyl)-phosphine: A structural and biological study , 2009 .
[31] M. Xanthopoulou,et al. Biological studies of organotin(IV) complexes with 2-mercaptopyrimidine , 2007 .
[32] M. Lagunas,et al. Synthesis of gold [Au3]3+, gold-silver [Au2Ag]3+, and gold-copper [Au2Cu]3+ loose clusters , 1993 .